Definitive Healthcare announces timing of its fourth quarter and full year 2023 financial results conference call and webcast
Definitive Healthcare (Nasdaq: DH) will release its fourth quarter and full year ended December 31, 2023 financial results on February 28, 2024.
Definitive Healthcare announces CEO transition
Jason Krantz, Founder and Executive Chairman, to serve as Interim CEO. Company reaffirms fourth quarter 2023 guidance and issues preliminary guidance…
Definitive Healthcare wins silver in the 2023 Stevie Awards for Great Employers
Definitive Healthcare wins a Silver Stevie Award® in the category for Employer of the Year – Health Products and Services.
Definitive Healthcare wins Great Place To Work Certification in India
Definitive Healthcare announces it has been awarded a Great Place To Work® Certification™ in India from November 2023 to November 2024.
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
Definitive Healthcare’s Board of Directors grants an inducement award to Carrie Lazorchak, Definitive Healthcare’s new Chief Revenue Officer.
Definitive Healthcare reports financial results for third quarter fiscal year 2023
Definitive Healthcare (Nasdaq: DH) announces financial results for the quarter ended September 30, 2023.
Definitive Healthcare announces timing of its third quarter 2023 financial results conference call and webcast
Definitive Healthcare (Nasdaq: DH) will report its third-quarter financial results on Thursday, November 2, 2023 at 5:00 p.m. ET.
Definitive Healthcare names Carrie Lazorchak as Chief Revenue Officer
Definitive Healthcare announced that Carrie Lazorchak has been named Chief Revenue Officer, effective November 1, 2023.
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
Definitive Healthcare’s Board of Directors grants inducement awards to former employees of Populi.